Conference abstract · 7 Dec 2015
Conference abstractPublished 24 Oct 2016
Development of a novel virus-trapping vaccine platform against genital herpes
University of Illinois at Chicago, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Efforts to generate an effective immuno-protective agent against recurrent genital infections caused by herpes simplex virus-2 (HSV-2) have seen only limited success. The virus can be transmitted sexually as well as from mothers to neonates. It is also a key facilitator of HIV co-acquisition. No vaccine or protective immunotherapy exists to control the viral transmission or dissemination. Here, we describe a nanoimmunotherapy approach using our uniquely designed zinc oxide tetrapod nanoparticles (ZOTEN). ZOTEN carry engineered oxygen vacancies, which allows HSV-2 to bind the nanoparticles with high affinity. As a result, ZOTEN can be used intravaginally as a microbicide that blocks HSV-2 genital infection in female BALB/c mice. The strong HSV-2 trapping ability of ZOTEN reduced local virus production, clinical symptoms of infection and effectively decreased the animal mortality rate. While preventing HSV-2 infection by virus trapping, the virus-bound ZOTEN promoted the presentation HSV-2 virions to mucosal antigen presenting cells. We demonstrate that dendritic cells can capture and process the bound virions for antigen presentation. Due to efficient processing of ZOTEN-bound virions a clear enhancement of cell and antibody-mediated responses was observed. Our results demonstrate that ZOTEN treatment can suppress not only a primary but also a re-infection by HSV-2. To conclude, we provide evidence for the protective efficacy of a virus-trapping vaccine platform against genital herpes infections.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 20 Feb 2017
The VCG platform facilitates mucosal and systemic vaccine delivery for induction of protective immunity in the female genital tract
Research article · 2018
Immunoinformatics Approach-Multiple Peptides Vaccine Design from Glycoprotein E of Herpes Simplex Virus-3
Research article · 30 Oct 2020
Incidences and Possible Risk Factors Associated with Subclinical Genital Herpes among Different Populations in Katsina State
Conference abstract · 18 Jun 2026
Rapid Vaccine Development Platforms for Emerging Viral Diseases
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Perspective · 10 Sep 2026
Cellular Pathways Involved in Mucosal Immunity and Protection Against Environmental Challenges
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Deepak Shukla”
- BylineArticles whose byline prints “Thessicar E Antoine”
- BylineArticles whose byline prints “Satvik R Hadigal”

